← Evidence map

ArticleScientific reports2026

Vitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations.

Jiaying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Vitexin attenuates gastric precancerous lesions with EGFR as a potential target based on network pharmacology and molecular simulations. | OpenQuestion